LC

Lee Cooper

Life sciences ventures, teaching, advocacy

Greater Boston

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Managing Director

    2024

  • Faculty Lecturer

    2021

    ENGS 15.03 - Ecosystem for Bio-Innovation

  • Lecturer

    2022

    Bio 196 - Exploratory Topics in Biology

2020 - 2024

  • Director, Venture Investments

    2020 - 2024

    Investments and/or board service include: Capstan Therapeutics, Recursion ($RXRX), Gandeeva Therapeutics, Senti Bio ($SNTI), Ukko, Pyxis ($PYXS), Cellino, Triumvira, Ukko, Century Tx ($IPSC), Ada Health, others

  • Entrepreneur In Residence

    2018 - 2019

    Biotech venture formation and investment diligence.

2018 - 2019

  • Founder

    2018 - 2019

    Patient-centered genomics company formed with support from RA Capital.

  • Associate Director, Business Development

    2015 - 2017

    Partnerships and financing to advance vaccines and therapeutics in infectious disease, oncology, and rare genetic disease.

2014 - 2014

  • Technology and Life Sciences Practice

    2014 - 2014

  • Strategy Consultant

    2009 - 2012

  • Director of International Programs

    2009 - 2009